XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Series 1 Convertible Preferred Stock
Series 2 Convertible Preferred Stock
Common Stock
Additional Paid in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 851,660 $ 21,952,000 $ 2,136 $ 36,843,326 $ (48,495,076) $ 11,154,046
Balance (in Shares) at Dec. 31, 2020 170,332 21,952 21,359,945      
Provision for compensation expense related to stock-based compensation 380,263 380,263
Issuance of warrants in connection with consulting agreement 212,923 212,923
Exercise of stock options into common stock $ 2 12,910 12,912
Exercise of stock options into common stock (in Shares)     16,000      
Net income/loss 1,237 1,237
Balance at Mar. 31, 2021 $ 851,660 $ 21,952,000 $ 2,138 37,449,422 (48,493,839) 11,761,381
Balance (in Shares) at Mar. 31, 2021 170,332 21,952 21,375,945      
Balance at Dec. 31, 2021 $ 851,660 $ 21,952,000 $ 2,144 38,560,117 (45,222,302) 16,143,619
Balance (in Shares) at Dec. 31, 2021 170,332 21,952 21,442,278      
Provision for compensation expense related to stock-based compensation 305,229 305,229
Issuance of warrants in connection with consulting agreement
Exercise of stock options into common stock $ 17 137,040 137,057
Exercise of stock options into common stock (in Shares)     162,956      
Net income/loss (2,380,935) (2,380,935)
Balance at Mar. 31, 2022 $ 851,660 $ 21,952,000 $ 2,161 $ 39,002,386 $ (47,603,237) $ 14,204,970
Balance (in Shares) at Mar. 31, 2022 170,332 21,952 21,605,234